IHI Forum Unites Health Care Professionals to Advance Healthy Aging, Equity, and Innovation

ANAHEIM, Calif.–(BUSINESS WIRE)–Dec 9, 2025–

The 2025 IHI Forum convened this morning with poignant and powerful opening remarks from Sylvia Trent-Adams, PhD, RN – her first as President and CEO of the Institute for Healthcare Improvement ( IHI ). In a fireside conversation with IHI President Emerita and Senior Fellow Maureen Bisognano, Dr. Trent-Adams urged the audience of 2,400 health care professionals to lean into “intentional collaboration” amid times of rapid change and to empower people and communities to shape solutions to the challenges they face.

This press release features multimedia. View the full release here:

“Navigating the future will demand intentional collaboration – leaders working deliberately across roles, departments, and systems to share power, strengthen capability, and solve problems close to the work,” said Dr. Trent-Adams. She reflected on lessons learned during her distinguished career in public service, sharing personal stories that reinforced her belief in the power of community-owned solutions.

Drawing on decades of experience at the front lines of care and leadership, Dr. Trent-Adams and Bisognano – both veteran health care providers and executives – explored what it means to lead improvement when systems are strained, communities are calling for change, and traditional approaches no longer suffice. Their conversation highlighted the enduring values that anchor IHI’s work, and the role the organization can play to equip people, create the right connections, and support teams to turn collaborative intent into real, sustained improvement.

Now in its 37th year, the IHI Forum brings together health care leaders, clinicians, patient advocates, and quality improvement professionals from around the world. The 2025 event features 190 sessions, 450 presenters, and more than 550 poster presentations showcasing real-world improvement projects. Keynote sessions remain a hallmark, inspiring fresh ideas and action to advance better care worldwide. From proven methods to emerging ideas, the Forum equips attendees with the tools and inspiration they need to lead change and advance better care in their communities.

Aging & Age-Friendly Care
IHI has deep expertise in improving care for older adults, most notably through the Age-Friendly Health Systems initiative – which now includes more than 5,500 sites recognized by IHI for providing the 4Ms of age-friendly care to 5.8 million older adults. Learnings from this impactful movement are featured prominently at Forum, and the new resources outlined below are now available to help provide evidence-based care to every older adult at every care interaction:

Numerous sessions at Forum will explore aging and age-friendly care, including:

Health Equity
IHI’s commitment to health equity is unwavering, and a Forum track dedicated to this topic includes a range of opportunities for attendees to learn and collaborate to accelerate the elimination of inequities in health and health care access, treatment, and outcomes. Half- and full-day workshops, Spotlight Sessions, Cinematic Conversations, and Pecha Kucha Presentations are offered throughout the conference.

A recently released white paper from IHI, “ Advancing Health Equity: An Approach to Systematically Identify and Evaluate Health Disparities,” will be explored during two sessions at the Forum. This freely available resource for health care organizations is quickly becoming one of IHI’s most downloaded white papers, demonstrating the need for a consistent method to identify, quantify, track, and report health equity gaps among patient populations.

Following are Forum sessions related to IHI’s new white paper, as well as other notable health equity programming:

Innovation in Health Care
IHI is continuously innovating to meet the evolving needs of health care organizations amid a rapidly changing technology landscape. One such innovation is IHI’s Care Operating System (IHI CareOS), which represents a fundamental shift in how health systems approach transformation, not by adding new technology, but by creating an integrated operating environment that helps organizations maximize their existing investments while planning strategically for the future. This approach unifies clinical care, operations, informatics, and analytics to ensure that critical daily workflows actively support clinicians rather than burden them. The outcome is a workforce empowered to practice with clarity, connection, and purpose—restoring the joy and mission at the heart of health care. Attendees can learn more about IHI CareOS at the following sessions:

The AI in Health Care track is one of the most popular among Forum attendees again this year, with sessions filling up as soon as they are announced. Highlights include:

Patient & Workforce Safety
With its unparalleled expertise in patient and workforce safety, IHI is rolling out new professional development offerings for health care professionals at various stages of their career. These courses complement IHI’s core safety and Open School programs, enabling students and professionals to develop competencies in the following clinical areas:

Safety is always a prevailing theme at IHI conferences, and this year’s Forum includes multiple tracks, sessions, and workshops addressing patient and workforce safety and well-being. Highlights include:

Certifications for Health Care Professionals
For the first time, in-person review courses for all four of IHI’s professional certifications took place at the IHI Forum. Full-day workshops were held during the pre-conference program with attendees taking the first step toward earning credentials that will help them build and apply knowledge across diverse health care roles and disciplines.

IHI’s original certification program – the Certified Professional in Patient Safety (CPPS TM ) – has surpassed the milestone of 8,000 individuals who have earned the credential. The Certified Professional in Human Factors in Health Care (CPHFH) credential was introduced this spring, enabling health care professionals to demonstrate a high level of proficiency in applying the core standards of human factors, systems thinking, and design to health care improvement. Starting in 2026, need-based scholarships for the CPPS and the CPHFH credentials will be named in honor of Lucian Leape, MD – the patient safety visionary and founding chairman of the IHI Lucian Leape Institute, who passed away earlier this year. The Certified Professional in Age-Friendly Health Care (CPAFH) and the Certified Professional in Clinical Health Equity (CPCHE) credentials were introduced this fall, and review courses began in September.

For those unable to attend the 2025 IHI Forum in person, a Virtual Pass provides on-demand access to all main stage events, including Keynotes, Spotlight Sessions, and more. Planning has already begun for the 2026 IHI Forum, which will take place December 6-9 in Phoenix, Arizona. Information about IHI’s global convenings can be found here.

About the Institute for Healthcare Improvement (IHI)
The Institute for Healthcare Improvement ( IHI ) is a leading, globally recognized not-for-profit health care improvement organization that has been applying evidence-based quality improvement methods to meet current and future health care challenges for more than 30 years. IHI provides millions of people in health care with methods, tools, and resources to make care better, safer, and more equitable; convenes experts to enable knowledge sharing and peer-learning; and advises health systems and hospitals of all sizes in improving their systems and outcomes at scale. IHI’s mission is to innovate and lead transformational improvement in health and health care worldwide.

Sylvia Trent-Adams and Maureen Bisognano during the opening keynote of the 2025 IHI Forum.

LONDON–(BUSINESS WIRE)–Dec 10, 2025–

Hims & Hers is deepening its commitment to the UK by bringing access to its comprehensive Weight Loss Programme to customers. This expansion includes the official introduction of the Hers platform, helping eligible women across the UK receive access to this holistic weight management care.

This press release features multimedia. View the full release here:

Sixty four percent of UK adults are overweight or living with obesity, yet access to GLP-1 treatment plans remains challenging on the NHS, and via the private sector due to surging demand and escalating costs. Removing barriers to care, the Hims & Hers digital platform provides eligible British women and men seamless access to its comprehensive, doctor-designed Weight Loss Programme.

Following a thorough, and clinically robust intake assessment conducted by GMC-registered doctors, eligible customers now have access to transparent pricing and personalised weight management programmes, which may include branded GLP-1 options, such as Mounjaro or Wegovy, and the oral non-prescription treatment option, Orlos. Licensed clinicians assess each individual’s medical history, suitability, and contraindications to guide appropriate treatment decisions. Critically, all customers have access to comprehensive support, including 24/7 care team access and content to help improve nutrition, movement, and sleep-based habits along their weight loss journey. This holistic programme is designed to support long-term health, helping customers manage their weight and adopt sustainable lifestyle habits.

Now for the first time through Hers, women in the UK deemed clinically suitable can access a new standard of weight management care that blends convenience with personalised support at every step of their journey. Hers’ customers receive ongoing clinician support through follow-ups and asynchronous messaging, along with treatment adjustments when necessary, keeping care seamless, conversational, and customer-centered. Hers is more than just a telehealth platform; it’s where clinical experience meets thoughtful care, resetting women’s expectations and standards for comprehensive and convenient care.

“The launch of Hims & Hers’ comprehensive Weight Loss Programme and the vital introduction of the Hers platform, our dedicated platform for women, represents a significant deepening of our commitment to the UK,” said David Meinertz, GM International of Hims & Hers. “Our doctor-designed treatment plans will complement the NHS by providing accessible, evidence-based, and sustainable long-term weight management care to those who need it, discreetly and conveniently. Our proven model is grounded in clinical excellence, oversight, and convenience, ensuring that every customer receives the thoughtful, thorough, and high-quality care they deserve.”

“Obesity is a global epidemic, and the scale of the challenge in the UK requires a comprehensive solution that prioritises long-term health over quick fixes,” said Craig Primack MD, Head of Weight Loss at Hims & Hers. “Bringing our trusted, comprehensive approach to the UK will help people lead fuller and healthier lives. And with the launch of the Hers platform, we are ensuring women have access to the dedicated, personalised care they need. Pairing clinically-proven treatments like GLP-1s with holistic support across nutrition and exercise helps make sustainable weight management achievable for the millions battling obesity today.”

Launching its Weight Loss Programme marks the company’s continued progress in its mission to make personalised care accessible to millions of people across the UK. Hims & Hers plans to continue to expand into more offerings as demand for access to personalised care continues to grow.

About Hims & Hers Health, Inc

Hims & Hers is the leading health and wellness platform on a mission to help the world feel great through the power of better health. We believe how you feel in your body and mind transforms how you show up in life. That’s why we’re building a future where nothing stands in the way of harnessing this power. Hims & Hers normalises health & wellness challenges—and innovates on their solutions—to make feeling happy and healthy achievable. No two people are the same, so the company provides access to personalised care designed for progress. For more information, please visit www.forhims.co.uk and www.forhers.co.uk

Cautionary Note Regarding Forward-Looking Statements

This communication includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. These forward-looking statements can be identified by the use of forward-looking terminology, including the words “believes,” “estimates,” “anticipates,” “expects,” “intends,” “plans,” “assume,” “may,” “will,” “likely,” “potential,” “projects,” “predicts,” “continue,” “goal,” “strategy,” “future,” “forecast,” “target,” “outlook,” “opportunity,” “project,” “confidence,” “foundation,” “groundwork,” or “should,” or, in each case, their negative or other variations or comparable terminology. There can be no assurance that actual results will not materially differ from expectations. Such statements include, but are not limited to, statements regarding our launch and expansion of the program, the introduction of the Hers platform in the UK, our expectations regarding customer adoption and subscriber growth, the pricing and availability of GLP-1 or other treatment options, our market opportunity in the UK, the growth of our weight management offering internationally, and our ability to comply with applicable legal, regulatory, and clinical requirements in the UK and other markets. These statements are based on management’s current expectations, but actual results may differ materially due to various factors.

Forward-looking statements are neither historical facts nor assurances of future performance. Instead, the forward-looking statements contained in this communication are based on our current expectations, assumptions, and beliefs concerning future developments and their potential effects on us. Future developments affecting us may not be those that we have anticipated. These forward-looking statements involve a number of risks, uncertainties (some of which are beyond our control) and other assumptions that may cause actual results or performance to be materially different from those expressed or implied by these forward-looking statements. These risks and uncertainties include, but are not limited to, the performance and acceptance of our weight loss specialty in the UK; our ability to successfully launch and scale the Hers platform in the UK; uncertainties relating to the availability, pricing, or supply of GLP-1 medications; changes in medical guidelines or regulatory requirements in the UK; competitive developments; operational and marketing costs; the impact of macroeconomic conditions on consumer demand; and other factors described in the Risk Factors and other sections of our most recently filed Quarterly Report on Form 10-Q, our most recently filed Annual Report on Form 10-K, and other reports we file from time to time with the Securities and Exchange Commission.

Should one or more of these risks or uncertainties materialize, or should any of our assumptions prove incorrect, actual results may vary in material respects from those projected in these forward-looking statements. The forward-looking statements contained in this communication are made only as of December 10, 2025. We undertake no obligation (and expressly disclaim any obligation) to update or revise any forward-looking statements, or to update the reasons actual results could differ materially from those anticipated in the forward-looking statements, whether as a result of new information, future events, or otherwise, except as may be required under applicable securities laws. By their nature, forward-looking statements involve risks and uncertainties because they relate to events and depend on circumstances that may or may not occur in the future. We caution you that forward-looking statements are not guarantees of future performance and that our actual results may differ materially from those made in or suggested by the forward-looking statements in this communication.

Now for the first time through Hers, women in the UK deemed clinically suitable can access a new standard of weight management care that blends convenience with personalised support at every step of their journey.